Latest Market Reactions News

Page 10 of 16
The A2 Milk Company has announced a fully franked ordinary dividend of NZD 0.115 per share for the six months ending June 2025, payable in October with flexible currency options for shareholders.
Victor Sage
Victor Sage
18 Aug 2025
Elanor Investors Group has firmly rejected an unsolicited takeover offer from Lederer Group for its Commercial Property Fund, while progressing a strategic $125 million investment with Rockworth Capital Partners and continuing asset sales to stabilise its balance sheet.
Eva Park
Eva Park
13 Aug 2025
ARC Funds Limited has withdrawn its scrip offer for the remaining shares in The Term Deposit Shop Pty Ltd after securing acceptances for just over 10% of the target shares, raising its ownership to nearly three-quarters of the company.
Claire Turing
Claire Turing
11 Aug 2025
The Federal Court of Australia has approved Ideagen’s acquisition of Envirosuite via a scheme of arrangement, setting the stage for a $0.09 per share cash payout to shareholders.
Sophie Babbage
Sophie Babbage
8 Aug 2025
Greatland Resources has downgraded its FY26 gold production target and significantly increased capital expenditure forecasts for its Telfer Project, prompting a sharp share price reaction and detailed ASX disclosure.
Maxwell Dee
Maxwell Dee
8 Aug 2025
Orcoda Limited has clarified the materiality and timing of disclosures related to its ACTA trial and new SaaS contracts, confirming compliance with ASX Listing Rules and explaining the rationale behind its announcements.
Sophie Babbage
Sophie Babbage
5 Aug 2025
Boss Energy has acknowledged significant upward revisions to operating and capital costs at its Honeymoon Uranium Project, alongside challenges in achieving production targets, prompting an independent review.
Maxwell Dee
Maxwell Dee
5 Aug 2025
Macarthur Minerals has successfully raised nearly $2 million through a rights issue, with Gold Valley Yilgarn Pty Ltd underwriting the shortfall and set to become a substantial shareholder pending approval.
Maxwell Dee
Maxwell Dee
4 Aug 2025
Alterity Therapeutics faces ASX scrutiny after mistakenly marking multiple announcements as market sensitive, prompting a review of its disclosure practices. The biotech denies any intent to manipulate its share price despite repeated errors.
Ada Torres
Ada Torres
4 Aug 2025
Donaco International shareholders have overwhelmingly approved a scheme of arrangement for On Nut Road Limited to acquire the company at a significant premium, setting the stage for a major ownership change pending court approval.
Victor Sage
Victor Sage
4 Aug 2025
Pacific Edge has successfully closed its Share Purchase Plan, raising $4.7 million and bringing total new equity to $20.7 million, surpassing initial targets. The capital raise awaits shareholder approval at the upcoming Annual Meeting.
Ada Torres
Ada Torres
4 Aug 2025
Envirosuite shareholders have decisively approved the proposed acquisition by Ideagen EVS BidCo Pty Limited, moving the deal closer to completion pending final court approval.
Sophie Babbage
Sophie Babbage
1 Aug 2025